A BRCA1 mutation is not associated with increased indicators of oxidative stress

Clinical Breast Cancer

Volumn 8, Issue 6, 2008, Pages 506-510

  Kotsopoulos, Joanne ^a,b   Shen, Honglei ^b   Rao, A Venketeshwer ^b   Poll, Aletta ^a   Ainsworth, Peter ^c   Fleshner, Neil ^d   Narod, Steven ^a  

^a WOMEN S COLLEGE HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c LONDON HEALTH SCIENCES CENTRE   (Canada)

^d UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

DNA damage; Lipid peroxidation; Malondialdehyde; Protein oxidation

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; BIOLOGICAL MARKER; BRCA1 PROTEIN; GENOMIC DNA; MALONALDEHYDE; THIOL; 8 OXO 7 HYDRODEOXYGUANOSINE; 8-OXO-7-HYDRODEOXYGUANOSINE; DEOXYGUANOSINE; DNA; DRUG DERIVATIVE; THIOL DERIVATIVE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD SAMPLING; BREAST CANCER; CANCER PREVENTION; CONTROLLED STUDY; DNA EXTRACTION; DNA SEQUENCE; FEMALE; GENE DELETION; GENE INSERTION; GENE MUTATION; GENETIC ASSOCIATION; GENETIC SCREENING; HETEROZYGOTE; HUMAN; IN VIVO STUDY; LIPID PEROXIDATION; LYMPHOCYTE; NONSENSE MUTATION; NORMAL HUMAN; ONCOGENE; OXIDATIVE STRESS; PROTEIN BLOOD LEVEL; QUESTIONNAIRE; AGED; BLOOD; BREAST TUMOR; GENETICS; METABOLISM; MIDDLE AGED; MUTATION; OXIDATION REDUCTION REACTION; TUMOR SUPPRESSOR GENE;

ADULT; AGED; BREAST NEOPLASMS; DEOXYGUANOSINE; DNA; FEMALE; GENES, BRCA1; HETEROZYGOTE; HUMANS; LIPID PEROXIDATION; MALONDIALDEHYDE; MIDDLE AGED; MUTATION; OXIDATION-REDUCTION; OXIDATIVE STRESS; SULFHYDRYL COMPOUNDS; YOUNG ADULT;

EID: 60549115503     PISSN: 15268209     EISSN: None     Source Type: Journal    
DOI: 10.3816/CBC.2008.n.061     Document Type: Article

References (47)

1. Ford D, - DF, Bishop DT, et al. Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. Lancet 1994; 343:692-5.
2. Scully R, Livingston DM. In search of the tumour-suppressor functions of BRCA1 and BRCA2. Nature 2000; 408:429-32.
3. Tutt A, Ashworth A. The relationship between the roles of BRCA genes in DNA repair and cancer predisposition. Trends Mol Med 2002; 8:571-6.
4. Venkitaraman AR. Cancer susceptibility and the functions of BRCA1 and BRCA2. Cell 2002; 108:171-82.
5. Baldeyron C, Jacquemin E, Smith J, et al. A single mutated BRCA1 allele leads to impaired fidelity of double strand break end-joining. Oncogene 2002; 21:1401-10.
6. Barwell J, Pangon L, Georgiou A, et al. Lymphocyte radiosensitivity in BRCA1 and BRCA2 mutation carriers and implications for breast cancer susceptibility. Int J Cancer 2007; 121:1631-6.
7. Kote-Jarai Z, Salmon A, Mengitsu T, et al. Increased level of chromosomal damage after irradiation of lymphocytes from BRCA1 mutation carriers. Br J Cancer 2006; 94:308-10.
8. Kowalska E, Narod SA, Huzarski T, et al. Increased rates of chromosome breakage in BRCA1 carriers are normalized by oral selenium supplementation. Cancer Epidemiol Biomarkers Prev 2005; 14:1302-6.
9. Speit G, Trenz K. Chromosomal mutagen sensitivity associated with mutations in BRCA genes. Cytogenet Genome Res 2004; 104:325-32.
10. Welcsh PL, Owens KN, King MC. Insights into the functions of BRCA1 and BRCA2. Trends Genet 2000; 16:69-74.
11. Bae I, Fan S, Meng Q, et al. BRCA1 induces antioxidant gene expression and resistance to oxidative stress. Cancer Res 2004; 64:7893-909.
12. Le Page F, Randrianarison V, Marot D, et al. BRCA1 and BRCA2 are necessary for the transcription-coupled repair of the oxidative 8-oxoguanine lesion in human cells. Cancer Res 2000; 60:5548-52.
13. Csizmadi I, Kahle L, Ullman R, et al. Adaptation and evaluation of the National Cancer Institute's Diet History Questionnaire and Nutrient Database for Canadian populations. Public Health Nutr 2007; 10:88-96.
14. Narod SA, Brunet JS, Ghadirian P, et al. Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study. Hereditary Breast Cancer Clinical Study Group. Lancet 2000; 356:1876-81.
15. Narod SA, Dube MP, Klijn J, et al. Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers. J Natl Cancer Inst 2002; 94:1773-9.
16. Lee IM, Paffenbarger RS Jr, Hsieh CC. Time trends in physical activity among college alumni, 1962-1988. Am J Epidemiol 1992; 135:915-25.
17. Ainsworth BE, Leon AS, Richardson MT, et al. Accuracy of the College Alumnus Physical Activity Questionnaire. J Clin Epidemiol 1993; 46:1403-11.
18. Albanes D, Conway JM, Taylor PR, et al. Validation and comparison of eight physical activity questionnaires. Epidemiology 1990; 1:65-71.
19. Washburn RA, Smith KW, Goldfield SR, et al. Reliability and physiologic correlates of the Harvard Alumni Activity Survey in a general population. J Clin Epidemiol 1991; 44:1319-26.
20. Subar AF, Thompson FE, Kipnis V, et al. Comparative validation of the Block, Willett, and National Cancer Institute food frequency questionnaires: the Eating at America's Table Study. Am J Epidemiol 2001; 154:1089-99.
21. Thompson FE, Subar AF, Brown CC, et al. Cognitive research enhances accuracy of food frequency questionnaire reports: results of an experimental validation study. J Am Diet Assoc 2002; 102:212-25.
22. Draper HH, Squires EJ, Mahmoodi H, et al. A comparative evaluation of thiobarbituric acid methods for the determination of malondialdehyde in biological materials. Free Radic Biol Med Jentzsch AM, Bachmann H, Furst P, et al. Improved analysis of malondialdehyde in human body fluids. Free Radic Biol Med 1996; 20:251-6.
23. Hu ML. Measurement of protein thiol groups and glutathione in plasma. Methods Enzymol 1994; 233:380-5.
24. Rao AV, Agarwal S. Bioavailability and in vivo antioxidant properties of lycopene from tomato products and their possible role in the prevention of cancer. Nutr Cancer 1998; 31:199-203.
25. Ames BN, Shigenaga MK, Hagen TM. Oxidants, antioxidants, and the degenerative diseases of aging. Proc Natl Acad Sci U S A 1993; 90:7915-22.
26. Block G. The data support a role for antioxidants in reducing cancer risk. Nutr Rev 1992; 50:207-13.
27. Castro L, Freeman BA. Reactive oxygen species in human health and disease. Nutrition 2001; 17:161, 163-5
28. Collins AR. Assays for oxidative stress and antioxidant status: applications to research into the biological effectiveness of polyphenols. Am J Clin Nutr 2005; 81(suppl):261S-7S.
29. Cavalieri E, Frenkel K, Liehr JG, et al. Estrogens as endogenous genotoxic agents-DNA adducts and mutations. J Natl Cancer Inst Monogr 2000; 27:75-93.
30. Djuric Z, Heilbrun LK, Simon MS, et al. Levels of 5-hydroxymethyl-2'- deoxyuridine in DNA from blood as a marker of breast cancer. Cancer 1996; 77:691-6.
31. Musarrat J, Arezina-Wilson J, Wani AA. Prognostic and aetiological relevance of 8-hydroxyguanosine in human breast carcinogenesis. Eur J Cancer 1996; 32A:1209-14.
32. Tagesson C, Kallberg M, Klintenberg C, et al. Determination of urinary 8-hydroxydeoxyguanosine by automated coupled-column high performance liquid chromatography: a powerful technique for assaying in vivo oxidative DNA damage in cancer patients. Eur J Cancer 1995; 31A:934-40.
33. Kumar K, Thangaraju M, Sachdanandam P. Changes observed in antioxidant system in the blood of postmenopausal women with breast cancer. Biochem Int 1991; 25:371-80.
34. Punnonen K, Ahotupa M, Asaishi K, et al. Antioxidant enzyme activities and oxidative stress in human breast cancer. J Cancer Res Clin Oncol 1994; 120:374-7.
35. Boyd NF, McGuire V. Evidence of lipid peroxidation in premenopausal women with mammographic dysplasia. Cancer Lett 1990; 50:31-7.
36. Boyd NF, McGuire V. The possible role of lipid peroxidation in breast cancer risk. Free Radic Biol Med 1991; 10:185-90.
37. Kang DH. Oxidative stress, DNA damage, and breast cancer. AACN Clin Issues 2002; 13:540-9.
38. Clemons M, Goss P. Estrogen and the risk of breast cancer. N Engl J Med 2001; 344:276-85.
39. Narod SA, Offit K. Prevention and management of hereditary breast cancer. J Clin Oncol 2005; 23:1656-63.
40. Bednarek-Tupikowska G, Tupikowski K, Bidzinska B, et al. Serum lipid peroxides and total antioxidant status in postmenopausal women on hormone replacement therapy. Gynecol Endocrinol 2004; 19:57-63.
41. Moorthy K, Sharma D, Basir SF, et al. Administration of estradiol and progesterone modulate the activities of antioxidant enzyme and aminotransferases in naturally menopausal rats. Exp Gerontol 2005; 40:295-302.
42. Gura T. Estrogen: key player in heart disease among women. Science 1995; 269:771-3.
43. Trevisan M, Browne R, Ram M, et al. Correlates of markers of oxidative status in the general population. Am J Epidemiol 2001; 154:348-56.
44. Unfer TC, Conterato GM, da Silva JC, et al. Emanuelli T. Influence of hormone replacement therapy on blood antioxidant enzymes in menopausal women. Clin Chim Acta 2006; 369:73-7.
45. Hakem R, de la Pompa JL, Sirard C, et al. The tumor suppressor gene Brca1 is required for embryonic cellular proliferation in the mouse. Cell 1996; 85:1009-23.
46. Marquis ST, Rajan JV, Wynshaw-Boris A, et al. The developmental pattern of Brca1 expression implies a role in differentiation of the breast and other tissues. Nat Genet 1995; 11:17-26.
47. Vaughn JP, Davis PL, Jarboe MD, et al. BRCA1 expression is induced before DNA synthesis in both normal and tumor-derived breast cells. Cell Growth Differ 1996; 7:711-5.